How Hydrogen Gas Could Help Fight Cancer: New Delivery Methods Explored
- Authors
- Jianfeng Wu, Tin Pou Lai, Liangyan Li, Yong Yuan, Yaling Wang, Guozheng Liu, Wangzhe Li, Liyun Zhang, Lei Wan
- Journal
- Journal of Controlled Release
- Year
- 2026
- DOI
- 10.1016/j.jconrel.2026.115137
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Cancer
- Body System
- Immune System
TL;DR
Scientists found that a simple gas called hydrogen might help fight cancer by reducing inflammation and protecting healthy cells, and they're now building tiny delivery systems to get it right to tumors—but they still need to do more testing to prove it actually works in real patients.
Key Finding
Molecular hydrogen shows potential as a supplementary cancer treatment through its antioxidant and anti-inflammatory effects, but clinical use requires solving delivery problems and conducting human trials.
Summary
This is a review article that examines how molecular hydrogen (H2)—a simple gas—might help treat cancer. Researchers have found that hydrogen appears to work by reducing harmful inflammation and protecting cells from damage. The article discusses new delivery methods using nanotechnology to get hydrogen directly to tumors, but notes that significant challenges remain before hydrogen therapy can be used in real patients, including improving how hydrogen is delivered and conducting proper clinical trials.
Practical Takeaway
While early research suggests hydrogen may have anti-cancer properties, this is a review of laboratory and animal studies—not human clinical trials. Anyone considering hydrogen water or hydrogen therapy for cancer should consult their oncologist, as the evidence for human benefit remains preliminary and unproven.
Abstract
Molecular hydrogen (H2) therapy has emerged as a promising adjunctive strategy in oncology, primarily attributed to its selective antioxidant, anti-inflammatory, and cytoprotective properties. Advances have been driven by the integration of mechanistic studies on H2-mediated redox regulation, immunoregulation, and cytoprotective effects with rapid developments in nanotechnology and catalysis. Nevertheless, the clinical translation of H2 therapy remains constrained by the present physicochemical limitations, including low solubility, non-targeted diffusion, the incomplete understanding of therapeutic mechanisms, etc. This review summarizes recent progress in molecular H2 research, spanning from fundamental mechanisms in cancer biology, the role in adjuvant therapy, to the development of innovative catalytic delivery systems, such as stimuli-responsive materials and hydrogenases. We outline the pertinent challenges and future directions, emphasizing the need for mechanistic elucidation and robust clinical validation to integrate hydrogen therapy into precision oncology paradigms.